Michael G. Kauffman
2015
In 2015, Michael G. Kauffman earned a total compensation of $4.6M as Chief Executive Officer at Karyopharm Therapeutics, a 602% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $3,896,500 |
| Salary | $500,000 |
| Other | $10,980 |
| Total | $4,557,480 |
Kauffman received $3.9M in option awards, accounting for 85% of the total pay in 2015.
Kauffman also received $150K in non-equity incentive plan, $500K in salary and $11K in other compensation.
Rankings
In 2015, Michael G. Kauffman's compensation ranked 1,820th out of 13,638 executives tracked by ExecPay. In other words, Kauffman earned more than 86.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,820 out of 13,638 | 87th |
Division Manufacturing | 655 out of 5,187 | 87th |
Major group Chemicals And Allied Products | 241 out of 1,857 | 87th |
Industry group Drugs | 187 out of 1,531 | 88th |
Industry Pharmaceutical Preparations | 150 out of 1,179 | 87th |
Source: SEC filing on April 28, 2017.
Kauffman's colleagues
We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2015.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019